Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Trading Update

30 Sep 2014 07:00

RNS Number : 9598S
Royal Bank of Scotland Group PLC
30 September 2014
 



The Royal Bank of Scotland Group plc ("RBS")

 

Q3 2014 Trading Update and Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

30 September 2014

 

Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

Ross McEwan, RBS Chief Executive, will present at the Bank of America Merrill Lynch Banking & Insurance Conference in London on Tuesday 30 September 2014 at 9.30am (UK time). 

 

A live audio webcast and accompanying slides will be available on our website www.rbs.com/ir shortly before the presentation commences.

 

Q3 2014 Trading Update

 

RBS today provides an update on Q3 2014 financial performance.

 

· Q3 2014 has seen continued improvement in economic conditions and asset prices in our key markets, including Ireland. This has supported a further quarter of strong operating performance by RBS Capital Resolution ("RCR"). We anticipate that RCR will record net impairment provision releases in the region of £0.5bn in Q3 2014.

 

· RCR's future overall costs and speed of wind-down remain subject to significant potential volatility. The potential exists, if market conditions remain favourable, for RCR to incur limited future impairments and disposal losses, and an accelerated timetable to achieve its wind-down goals.

 

· Rising Irish residential property prices combined with pro-active debt management has resulted in lower arrears in Ulster (excluding RCR), within Personal & Business Banking. As a result we expect Ulster to record net provision releases in the region of £0.3bn in Q3 2014. The potential exists for further releases in future, if market conditions continue to improve.

 

· There has been an absence of large one-off impairments and lower levels of new non-performing loans in the rest of RBS's business during Q3 2014.

 

· RBS now expects to significantly outperform its previous guidance of c£1bn total impairments for FY 2014. Previously disclosed uncertainties remain, particularly relating to conduct and litigation matters.

 

· Corporate & Institutional Banking revenues have been weaker than anticipated in the third quarter.

 

· RBS took advantage of improved market prices to dispose of c€9bn legacy available for sale debt securities. These disposals generated a loss of around £0.2bn in Centre revenues. We expect these transactions to be moderately capital ratio accretive.

 

The figures quoted in this statement are preliminary estimates and unaudited. RBS will release its Q3 2014 Interim Management Statement on 31 October 2014.

 

 

For further information:

 

Investor Relations

Richard O'Connor

Head of Investor Relations

+44 (0) 20 7672 1758

 

Media Relations

+44 (0) 131 523 4205

 

If you would like a copy of this presentation in a different format (eg. large print, audio or Braille) please contact the Investor Relations team on +44 20 7672 1758 or investor.relations@rbs.com.

 

This release contains 'forward-looking statements' as that term is defined in the United States Private Securities Litigation Reform Act of 1995. Forward looking statements are statements that are not historical facts and can be identified by the use of forward-looking terminology such as statements that include the words 'expect', 'estimate', 'project', 'anticipate', 'believes', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'will', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on such expressions or by the forward looking nature of discussions of strategy, plans, targets and intentions. . These statements are based on current plans, estimates and projections, and are subject to inherent risks, uncertainties and other factors which could cause actual results to differ materially from the future results expressed or implied by such forward-looking statements. The forward-looking statements contained in this release speak only as of the date of this announcement, and the Group does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKKDPPBKKKCN
Date   Source Headline
31st Jan 20185:12 pmRNSTotal Voting Rights
29th Jan 20182:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20185:05 pmRNSPublication of Suppl.Prospcts
29th Dec 20171:20 pmRNSDirector/PDMR Shareholding
29th Dec 20171:20 pmRNSTotal Voting Rights
21st Dec 201710:14 amRNSSegmental Reporting Restatement Document
21st Dec 20179:00 amRNSDirectorate Change
7th Dec 20175:23 pmRNSPublication of a Prospectus
30th Nov 20173:29 pmRNSTotal Voting Rights
29th Nov 201711:51 amRNSHolding(s) in Company
28th Nov 20177:06 amRNS2017 Bank of England Stress Test Results
23rd Nov 20175:00 pmRNSDividend Declaration
21st Nov 20173:53 pmRNSUpdate on Ring-Fencing Plans
8th Nov 20174:34 pmRNSHolding(s) in Company
8th Nov 20173:28 pmRNSDirector/PDMR Shareholding
8th Nov 20172:40 pmRNSHolding(s) in Company
3rd Nov 201711:55 amRNSHolding(s) in Company
31st Oct 20171:41 pmRNSTotal Voting Rights
27th Oct 20174:17 pmRNSPublication of Suppl.Prospcts
27th Oct 20177:00 amRNSQ3 2017 Interim Management Statement
26th Oct 20172:13 pmRNSHolding(s) in Company
25th Oct 20171:53 pmRNSHolding(s) in Company
24th Oct 20175:37 pmRNSDisposal of shareholdings in Euroclear plc
24th Oct 20171:35 pmRNSHolding(s) in Company
24th Oct 201712:56 pmRNSHolding(s) in Company
20th Oct 201712:03 pmRNSHolding(s) in Company
17th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20175:11 pmRNSNotices of Redemption
5th Oct 201712:24 pmRNSBlock listing Interim Review
29th Sep 20172:39 pmRNSTotal Voting Rights
29th Sep 20171:55 pmRNSThe Royal Bank of Scotland N.V. Interim Results
27th Sep 20176:20 pmRNSAllotment and Issue of New Ordinary Shares
26th Sep 20179:00 amRNSBank of America Merrill Lynch Conference
18th Sep 20175:15 pmRNSEC formally approves Alternative Remedies Package
18th Sep 20171:17 pmRNSHolding(s) in Company
14th Sep 20173:19 pmRNSHolding(s) in Company
11th Sep 20171:30 pmRNSBarclays Global Financial Services Conference
1st Sep 20172:35 pmRNSDirectorate Change
31st Aug 20179:50 amRNSTotal Voting Rights
23rd Aug 20176:11 pmRNSDividend Declaration
7th Aug 20175:43 pmRNSNotice of Redemption
7th Aug 20172:21 pmRNSPublication of Suppl.Prospcts
7th Aug 20177:00 amRNSRedemption of Non-cumulative Dollar Pref. Shares
4th Aug 20174:48 pmRNSRedemption of Non-cumulative Preference Shares
4th Aug 20177:20 amRNSTechnology & Innovation Committee
4th Aug 20177:00 amRNSHalf-year Report
31st Jul 20172:29 pmRNSTotal Voting Rights
26th Jul 20174:31 pmRNSUpdate on RBS's remaining State Aid obligation
12th Jul 20171:34 pmRNSSettlement reached with the FHFA re US RMBS claims
12th Jul 201711:00 amRNSTR-1 Notification of Major Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.